Author

Syed Monem Rizvi

Observed names: S M A Rizvi, S Rizvi, S. M. A. Rizvi, S. M. Rizvi, S. Rizvi, S.M. Rizvi, Syed M Abbas Rizvi, Syed M. A. Rizvi, Syed M. Abbas Rizvi, Syed M. Rizvi, Syed M.A. Rizvi, Syed Rizvi

Institution: University of Michigan

Observed institutions: BC Cancer Agency, The University of Sydney, Pennsylvania State University, Queen's University, University of Wollongong, University of Michigan, UNSW Sydney, Michigan Medicine, St George Hospital, R&D Systems (United States), St. George Hospital, Canadian Cancer Trials Group, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center

ORCID: 0000-0002-6150-6801

Observed ORCID: 0000-0002-6150-6801

OpenAlex ID: A5044115470

Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination

2021 · Jiali Yu, Michael D. Green, et al. · Nature Medicine · 1,001

The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis

2020 · Sho Kitamoto, Hiroko Nagao-Kitamoto, et al. · Cell · 681

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis

2020 · Johann E. Gudjonsson, Lam C. Tsoi, et al. · JCI Insight · 188

PDF

Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation

2022 · Allison C. Billi, Feiyang Ma, et al. · Science Translational Medicine · 150

PDF

Intralesional targeted alpha therapy for metastatic melanoma

2005 · Barry J Allen, Chand Raja, et al. · Cancer Biology & Therapy · 124

PDF

MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by 213Bi-C595 radioimmunoconjugate

2004 · C F Qu, Y Li, et al. · British Journal of Cancer · 123

PDF

Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma

2007 · Chand Raja, Peter Graham, et al. · Cancer Biology & Therapy · 110

PDF

MHC class I assembly: out and about

2008 · Malini Raghavan, Natasha Del Cid, et al. · Trends in Immunology · 106

Distinct Assembly Profiles of HLA-B Molecules

2014 · Syed Monem Rizvi, Nasir Salam, et al. · The Journal of Immunology · 103

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen

2002 · Y Li, Z Tian, et al. · Prostate Cancer and Prostatic Diseases · 84

Modes of Calreticulin Recruitment to the Major Histocompatibility Complex Class I Assembly Pathway

2009 · Natasha Del Cid, Elise Jeffery, et al. · Journal of Biological Chemistry · 79

The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity

2019 · Allison C. Billi, Mehrnaz Gharaee-Kermani, et al. · JCI Insight · 77

PDF

In vivo studies of Gd‐DTPA‐monoclonal antibody and gd‐porphyrins: Potential magnetic resonance imaging contrast agents for melanoma

2001 · D. Shahbazi‐Gahrouei, M. Williams, et al. · Journal of Magnetic Resonance Imaging · 77

PDF

A Polypeptide Binding Conformation of Calreticulin Is Induced by Heat Shock, Calcium Depletion, or by Deletion of the C-Terminal Acidic Region

2004 · Syed Monem Rizvi, Laura Mancino, et al. · Molecular Cell · 75

PDF

213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model

2002 · Y Li, S M A Rizvi, et al. · British Journal of Cancer · 73

Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance

2024 · Jiali Yu, Yijian Yan, et al. · Cell · 63

Preclinical studies of targeted α therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2

2003 · B J Allen, Z Tian, et al. · British Journal of Cancer · 62

PDF

Targeted alpha therapy for cancer

2004 · Barry J Allen, Chand Raja, et al. · Physics in Medicine and Biology · 59

B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity

2021 · Lisa Abernathy-Close, Stephanie Lazar, et al. · Frontiers in Immunology · 53

Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model

2008 · Emma Y. Song, Chang F Qu, et al. · Cancer Biology & Therapy · 52

PDF

Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer

2005 · Chang F. Qu, Emma Y. Song, et al. · Clinical & Experimental Metastasis · 46

In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A”-C595

2005 · Chang F. Qu, Yan J. Song, et al. · Cancer Biology & Therapy · 42

PDF

Direct peptide-regulatable interactions between MHC class I molecules and tapasin

2006 · Syed Monem Rizvi, Malini Raghavan · Proceedings of the National Academy of Sciences · 41

Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer

2007 · Barry J Allen, Chand Raja, et al. · Physics in Medicine and Biology · 39

Glycan-dependent and -independent Interactions Contribute to Cellular Substrate Recruitment by Calreticulin

2013 · Sanjeeva J. Wijeyesakere, Syed M. Rizvi, et al. · Journal of Biological Chemistry · 38

PDF

Works count: 65

Citation count: 4,172

H-index: 30

I10-index: 50